Arcturus Therapeutics
ARCT
#9138
Rank
$0.17 B
Marketcap
$6.20
Share price
3.41%
Change (1 day)
-49.14%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2026 (TTM): -$77.88 Million USD

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are $42.35 Million USD. In 2025 the company made an earning of -$65.78 Million USD, an increase over its 2024 earnings that were of -$92.29 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$77.88 Million18.4%
2025 -$65.78 Million-28.73%
2024 -$92.29 Million240.24%
2023 -$27.13 Million-298.78%
2022 $13.64 M-106.79%
2021 -$0.21 Billion181.83%
2020 -$71.32 Million183.72%
2019 -$25.14 Million16.93%
2018 -$21.5 Million154.5%
2017 -$8.45 Million-65.36%
2016 -$24.39 Million25.93%
2015 -$19.37 Million-41.04%
2014 -$32.85 Million219.64%
2013 -$10.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-$2.17 Million-97.23% Bahamas
NRC Health
NRC
$19.61 M-125.19%๐Ÿ‡บ๐Ÿ‡ธ USA